People: Vinci SA (SGEF.PA)

SGEF.PA on Paris Stock Exchange

11:35am EDT
Price Change (% chg)

€0.66 (+1.50%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Pragnell, Michael 

Brief Biography

Mr. Michael P. Pragnell has been Independent Director of Vinci SA since May 14, 2009. He is Member of the Company’s Audit Committee. He currently serves as the Chairman of Cancer Research UK. He graduated from Saint Johns College, from the University of Oxford with a degree in Modern Languages and from INSEAD Business School with a Masters of Business Administration degree. In 1968, he joined Courtaulds Ltd where he held positions in marketing and sales. In 1974, he joined First National Bank of Chicago in the international department. From 1975 to 1995, he held various positions within the Courtaulds group: in marketing at International Paint plc (1975–1985), as Chief Executive Officer of National Plastics (1985-1986), as Chief Executive Officer of International Paint plc (1986–1992) and as Chief Financial Officer (1992–1994) of Courtaulds plc, where he was appointed to the Board of Directors in 1990. From 1995 to 2000, he was Chief Executive Officer of Zeneca Agrochemicals and a Member of the Executive Committee of Zeneca plc (now known as AstraZeneca plc), and was appointed to the Board of Directors in 1997. In 2000, he was appointed founding Chief Executive Officer and Chairman of the Executive Committee of Syngenta AG, where he is also a founder member of the Board of Directors. From 2002 to 2005, he was Chairman of CropLife International. Mr. Pragnell is also a Director of INSEAD.

Basic Compensation

Total Annual Compensation, EUR Long-Term Incentive Plans, EUR All Other, EUR Fiscal Year Total, EUR
55,000 -- -- 55,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Search Stocks